Jiwon Oh

Summary

Affiliation: Johns Hopkins Bloomberg School of Public Health
Country: USA

Publications

  1. doi request reprint Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
    CNS Drugs 27:591-609. 2013
  2. pmc Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, USA
    Neurology 80:540-7. 2013
  3. doi request reprint Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, 600 N Wolfe Street, Pathology 627, Baltimore, MD 21287, USA
    Mult Scler 19:427-35. 2013
  4. ncbi request reprint Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis
    Jiwon Oh
    From the Department of Neurology J Oh, S S, P A C, S D N, Johns Hopkins University, Baltimore and Neuroimmunology Branch I C, J Ohayon, B B, National Institute of Neurological Disorders and Stroke, Bethesda, MD
    Neurology 82:984-8. 2014
  5. ncbi request reprint Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis
    Shiv Saidha
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
    JAMA Neurol 70:34-43. 2013
  6. pmc Automatic magnetic resonance spinal cord segmentation with topology constraints for variable fields of view
    Min Chen
    Department of Electrical and Computer Engineering, The Johns Hopkins University, Baltimore, MD, USA Translational Neuroradiology Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA Electronic address
    Neuroimage 83:1051-62. 2013
  7. ncbi request reprint Teriflunomide for the treatment of multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA
    Semin Neurol 33:45-55. 2013
  8. doi request reprint Emerging injectable therapies for multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA Electronic address
    Lancet Neurol 12:1115-26. 2013
  9. pmc Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
    Shiv Saidha
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Lancet Neurol 11:963-72. 2012
  10. pmc An update of teriflunomide for treatment of multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA Division of Neurology, St Michael s Hospital, Toronto, ON, Canada
    Ther Clin Risk Manag 9:177-90. 2013

Detail Information

Publications10

  1. doi request reprint Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
    CNS Drugs 27:591-609. 2013
    ..This review discusses salient points on the safety and clinical efficacy of the approved and emerging novel oral therapies in RRMS, including fingolimod, teriflunomide, dimethyl fumarate, laquinimod, and cladribine. ..
  2. pmc Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, USA
    Neurology 80:540-7. 2013
    ..We aimed to assess whether quantitative diffusion tensor and magnetization transfer imaging measures in the SC can distinguish MS cases of comparable lesion burdens with high and low disability...
  3. doi request reprint Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, 600 N Wolfe Street, Pathology 627, Baltimore, MD 21287, USA
    Mult Scler 19:427-35. 2013
    ..Using quantitative MRI indices sensitive to early and late microstructural changes in the spinal cord, we searched for the presence of better correlations between MRI measures and clinical status in MS...
  4. ncbi request reprint Daclizumab-induced adverse events in multiple organ systems in multiple sclerosis
    Jiwon Oh
    From the Department of Neurology J Oh, S S, P A C, S D N, Johns Hopkins University, Baltimore and Neuroimmunology Branch I C, J Ohayon, B B, National Institute of Neurological Disorders and Stroke, Bethesda, MD
    Neurology 82:984-8. 2014
    ..To report 3 patients with multiple sclerosis (MS) who presented with daclizumab-related adverse events (AEs) in multiple organ systems...
  5. ncbi request reprint Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis
    Shiv Saidha
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
    JAMA Neurol 70:34-43. 2013
    ....
  6. pmc Automatic magnetic resonance spinal cord segmentation with topology constraints for variable fields of view
    Min Chen
    Department of Electrical and Computer Engineering, The Johns Hopkins University, Baltimore, MD, USA Translational Neuroradiology Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA Electronic address
    Neuroimage 83:1051-62. 2013
    ..Results were found to be highly accurate in comparison to manual segmentations. A pilot study was carried out to demonstrate the potential utility of this new method for research and clinical studies of multiple sclerosis. ..
  7. ncbi request reprint Teriflunomide for the treatment of multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA
    Semin Neurol 33:45-55. 2013
    ....
  8. doi request reprint Emerging injectable therapies for multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA Electronic address
    Lancet Neurol 12:1115-26. 2013
    ..Further clarification of purported mechanisms of action and continued surveillance will be essential to establish the safety and clinical efficacy of these drugs in patients with relapsing-remitting MS. ..
  9. pmc Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study
    Shiv Saidha
    Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Lancet Neurol 11:963-72. 2012
    ..We aimed to determine whether MMO of the INL, and increased thickness of the INL are associated with disease activity or disability progression...
  10. pmc An update of teriflunomide for treatment of multiple sclerosis
    Jiwon Oh
    Department of Neurology, Johns Hopkins University, Baltimore, MD, USA Division of Neurology, St Michael s Hospital, Toronto, ON, Canada
    Ther Clin Risk Manag 9:177-90. 2013
    ....